HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced today that the company’s ...

Thank you for standing by. My name is Gill, and I will be your operator for today's call. At this time, I would like to welcome each and every one of you to the Bio-Rad Second Quarter 2025 Results ...

We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Bio-Rad Laboratories, Inc. stands tenth on our list and is currently making waves for launching a new ...

It’s the most wonderful time of the yeeaaarrrr! No, we aren’t talking about Christmas, although we do love it. We are talking about San Diego Comic-Con, the biggest event for geeks and nerds in ...

Introduction: Flavonoids are the most abundant secondary metabolites in plants and play important roles in plant growth, environmental adaptation, and human health. Tobacco serves as a vital cash crop ...

Bio-Rad Laboratories (NYSE:BIO) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table provides a quick ...

I rate Bio-Rad (BIO) with a buy rating. I start by mentioning that the low growth perspective is the negative aspect. For 2025, the company expects a 0.25% growth rate for its revenues, which might ...

Bio-Rad develops products and solutions for the life sciences research and clinical diagnostic markets and enjoys niche market leadership in diagnostic quality controls, antigens, and digital ...

View post: Reported Kansas City Current Coaching Hire Has Fans Scratching Their Heads The Boston Red Sox are adding a bold new look to their wardrobe for the 2025 season, introducing a fresh City ...

Feb 19 (Reuters) - Diagnostics company Bio-Rad (BIO.N), opens new tab has been sued by the California Institute of Technology for allegedly misusing the school's patented technology for analyzing ...